Reach Us +1-217-403-9671
Editor - Jamaluddin Shaikh | University of Nizwa | 13956
ISSN: 2376-0419

Journal of Pharmaceutical Care & Health Systems
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Jamaluddin Shaikh

Jamaluddin Shaikh
Jamaluddin Shaikh
Associate Professor
School of Pharmacy
University of Nizwa
Tel: 968-25446713
University of Nizwa


I, Jamaluddin Shaikh, am an Associate Professor at the School of Pharmacy, College of Pharmacy and Nursing, University of Nizwa, Sultanate of Oman. I received my B. Sc. in Chemistry, M. Sc. and Ph. D. in Biochemistry from University of Calcutta, Calcutta, India. In 2004, I moved to US and joined to Professor Carey Pope’s Neurotoxicology Laboratory at Oklahoma State University as a Postdoctoral Research Fellow. After completion of two years, I joined to Professor Rae Matsumoto’s Neuropharmacology Laboratory at School of Pharmacy, Oklahoma University Health Sciences Center as a Research Associate. In the same year, I moved with Professor Matsumoto to the School of Pharmacy, University of Mississippi and promoted to Research Scientist (2004-2008). Subsequently, I moved to the School of Pharmacy, West Virginia University Health Sciences Center (2008-2010) with Professor Matsumoto. Since 2010, I am working as an Associate Professor at the School of Pharmacy, University of Nizwa, Sultanate of Oman.

Research Interest

I use a multidisciplinary approach to evaluate the effects of drugs on the brain. Much of my current research focuses on the development of new drugs for the treatment of neurological and psychiatric disorders. Recently, we developed new classes of drugs with powerful anti-cocaine and anti-methamphetamine actions in animals. Much of research is now focused on optimizing these compounds, and identifying the cellular and molecular mechanisms through which they exert their beneficial actions. In addition, we recently developed and characterized a new class of compounds that changes animal behavior and neuronal structure and function in ways that predict favorable antidepressant potential. By targeting new mechanisms of action, these compounds are expected to help individuals who do not respond to existing medications.



Global Speakers in the subject

Global Experts in the subject

Relevant Conferences